Research Topics
| Sara A CoryaSummaryAffiliation: Eli Lilly and Company Country: USA Publications
|
Detail Information
Publications
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depressionSara A Corya
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
Depress Anxiety 23:364-72. 2006..e., olanzapine and fluoxetine), showed a rapid onset of antidepressant effect, and was effective in this TRD sample. At the study end point, OFC, fluoxetine, venlafaxine, and low-dose OFC all appeared to be similarly effective...- A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depressionSara A Corya
Lilly Research Laboratories, Indianapolis, Ind, USA
J Clin Psychiatry 67:798-806. 2006..The present analyses examined the efficacy and safety of longer term treatment with olanzapine-fluoxetine combination or olanzapine monotherapy in a 6-month open-label extension study... - Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label studySara A Corya
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
J Clin Psychiatry 64:1349-56. 2003..Long-term efficacy and safety were therefore investigated in a group of patients with major depressive disorder (MDD) with and without TRD... - Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorderScott W Andersen
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
J Clin Psychiatry 66:1468-76. 2005..It is important that prescribers balance the risk of weight gain with the benefit of treatment for individual patients with depression... 
Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of casesHolland C Detke
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
BMC Psychiatry 10:43. 2010..During clinical trials, a post-injection syndrome characterized by signs of delirium and/or excessive sedation was identified in a small percentage of patients following injection with olanzapine LAI...
Metabolic parameters in patients treated with olanzapine or other atypical antipsychoticsOlawale Osuntokun
Eli Lilly and Company, Indianapolis, IN 46285 6156, USA
J Psychopharmacol 25:630-8. 2011..04 mmol/L [N = 220; ME = 194], p = 0.048). The study concluded that there are changes with varying frequencies and magnitude in some metabolic parameters in patients treated with olanzapine compared with other atypical antipsychotics...- Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depressionPaul E Keck
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
J Clin Psychiatry 66:611-6. 2005..These subanalyses compare treatment-emergent mania rates in bipolar I depressed patients treated with olanzapine, placebo, or olanzapine/fluoxetine combination... - Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistanceRichard C Shelton
Department of Psychiatry, Vanderbilt University, Nashville, TN 37212, USA
J Clin Psychiatry 66:1289-97. 2005.... - A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorderMichael E Thase
Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
J Clin Psychiatry 68:224-36. 2007..Two parallel, 8-week double-blind studies compared olanzapine/fluoxetine combination, olanzapine, and fluoxetine in outpatients with treatment-resistant depression (TRD)...